TickerFacts.

Exagen Inc. (XGN): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$2.10M
Year ended 2025-12-31
$2.40M
Trailing 12 months to 2026-06-30
+9.5%
3-year compound annual growth
+33.2%
5-year compound annual growth
$2.20M2018-12-31: $600.0K2019-12-31: $600.0K2020-12-31: $500.0K2021-12-31: $900.0K2022-12-31: $1.60M2023-12-31: $2.20M2024-12-31: $1.70M2025-12-31: $2.10M$2.10M
2018-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$2.10M+23.5%2026-03-10, From 2025-01-01
2024-12-31$1.70M-22.7%2026-03-10, From 2024-01-01
2023-12-31$2.20M+37.5%2025-03-11, From 2023-01-01
2022-12-31$1.60M+77.8%2024-03-18, From 2022-01-01
2021-12-31$900.0K+80.0%2023-03-20, From 2021-01-01
2020-12-31$500.0K-16.7%2022-03-22, From 2020-01-01
2019-12-31$600.0K0.0%2021-03-16, From 2019-01-01
2018-12-31$600.0Kn/a2020-03-25, From 2018-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Exagen Inc. (XGN)2025-12-31$2.10M+23.5%
Personalis, Inc. (PSNL)2025-12-31$10.05M-8.2%
Biodesix Inc (BDSX)2025-12-31$5.67M-1.8%
American Shared Hospital Services (AMS)2025-12-31$5.71M-7.5%
BillionToOne, Inc. (BLLN)2025-12-31$6.90M-1.4%
Fulgent Genetics, Inc. (FLGT)2025-12-31$24.12M-3.2%
Castle Biosciences Inc (CSTL)2025-12-31$40.77M+154.9%
CareDx, Inc. (CDNA)2025-12-31$15.02M+5.8%
Veracyte, Inc. (VCYT)2025-12-31$21.41M-8.7%

Compare XGN, PSNL, BDSX, AMS side by side · Screen every company in Services-Medical Laboratories ↗